Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation‐enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis
Giuseppe Gaetano Loscocco, Giada Rotunno, Francesco Mannelli, et al.
American Journal of Hematology (2023) Vol. 99, Iss. 1, pp. 68-78
Open Access | Times Cited: 16

Showing 16 citing articles:

RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives
Dana Alawieh, Leila Cysique-Foinlan, Christophe Willekens, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 16
TP53 Mutations in Myeloproliferative Neoplasms: Context‐Dependent Evaluation of Prognostic Relevance
Ayalew Tefferi, Maymona Abdelmagid, Giuseppe Gaetano Loscocco, et al.
American Journal of Hematology (2025)
Open Access | Times Cited: 3
Momelotinib expands the therapeutic armamentarium for myelofibrosis: Impact on hierarchy of treatment choices
Ayalew Tefferi, Animesh Pardanani, Naseema Gangat
American Journal of Hematology (2024) Vol. 99, Iss. 2, pp. 300-308
Closed Access | Times Cited: 9
Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment Advancements
Tanvi Verma, Nikolaos Papadantonakis, Deniz Peker Barclift, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 514-514
Open Access | Times Cited: 5
The prognostic impact of non‐driver gene mutations and variant allele frequency in primary myelofibrosis
Alberto Hernández, Á. Villaverde-Ramiro, Eduardo Arellano‐Rodrigo, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 4, pp. 755-758
Open Access | Times Cited: 5
Clearance of Driver Mutations after Transplantation for Myelofibrosis
Nico Gagelmann, Marie Quarder, Anita Badbaran, et al.
New England Journal of Medicine (2025) Vol. 392, Iss. 2, pp. 150-160
Closed Access
Food effect trial of the pharmacokinetics and safety of TQ05105 in healthy Chinese subjects
Jun Dai, Cheng Yang, Yannan Zhou, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Closed Access
It's More Than Complex: Further Insights Into TP53 in MPN
Nico Gagelmann, Nicolaus Krogër
American Journal of Hematology (2025)
Open Access
SOHO State of the Art Updates and Next Questions | Challenging Scenarios in the Management of Myeloproliferative Neoplasms
Joseph Cannova, Shiv Shah, Anand Patel
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
Non-myeloablative Allogeneic Haematopoietic Stem Cell Transplantation for Myelofibrosis. A Population-Based Study from Eastern Denmark
Morten Orebo Holmström, Lia Minculescu, K. Nørgaard, et al.
Transplantation and Cellular Therapy (2025)
Open Access
Национальные клинические рекомендации по диагностике и лечению Ph-негативных миелопролиферативных новообразований (истинной полицитемии, эссенциальной тромбоцитемии, первичного миелофиброза) (редакция 2024 г.)
Анаит Левоновна Меликян, Irina N. Subortseva, А. М. Ковригина, et al.
Clinical oncohematology (2024) Vol. 17, Iss. 3, pp. 291-334
Open Access | Times Cited: 1
Risk models in myelofibrosis—the past, present, and future
Ayalew Tefferi, Alessandro M. Vannucchi
American Journal of Hematology (2024) Vol. 99, Iss. 4, pp. 519-522
Closed Access
Challenging Scenarios in the Management of Myeloproliferative Neoplasms
Anand Patel
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, pp. S49-S52
Closed Access
Inter-racial genetic differences in myelofibrosis: a diverse inner-city center analysis
Josette Kamel, John Yan, Bradley Rockwell, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-4
Closed Access
When and how to transplant in myelofibrosis – recent trends
Naman Sharma, Giuseppe Gaetano Loscocco, Naseema Gangat, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-19
Closed Access
Prognostic and Predictive Models in Myelofibrosis
Barbara Mora, Cristina Bucelli, Daniele Cattaneo, et al.
Current Hematologic Malignancy Reports (2024) Vol. 19, Iss. 5, pp. 223-235
Open Access
Page 1

Scroll to top